EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Design, Synthesis, and Biological Evaluation of 2-Mercaptobenzoxazole Derivatives as Potential Multi-Kinase Inhibitors

Mohammed M Alanazi iD, Saleh Aldawas, Nawaf A Alsaif

Pharmaceuticals · 09.01.2023 · 16 (1) · 97

DOI: 10.3390/ph16010097 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 09.01.2023. Verfasst von Mohammed M Alanazi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11541, Saudi Arabia. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research & Innovation "Ministry of Education" in Saudi Arabia, Deputyship for Research & Innovation “Ministry of Education”.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A series of 12 compounds was designed and synthesized, based on 2-mercaptobenzoxazole derivatives containing either the substituted benzenes 4a–d, substituted isatins 5a–f, or heterocycles 6a–b. The in vitro antiproliferative activity of the compounds was evaluated against hepatocellular carcinoma (HepG2), mammary gland cancer (MCF-7), breast cancer (MDA-MB-231), and the epithelioid cervix carcinoma (HeLa) cancer cell lines. Compounds 4b, 4d, 5d, and 6b had the most potent antiproliferative activity, with IC50 values ranging from 2.14 to 19.34 µM, compared to the reference drugs, doxorubicin and sunitinib. Compound 6b revealed a remarkably broad antitumor activity pattern against HepG2 (IC50 6.83 µM), MCF-7 (IC50 3.64 µM), MDA-MB-231 (IC50 2.14 µM), and HeLa (IC50 5.18 µM). In addition, compound 6b showed potent inhibitory activities against EGFR, HER2, VEGFR2, and the CDK2 protein kinase enzymes, with IC50 values of 0.279, 0.224, 0.565, and 0.886 µM, respectively. Moreover, compound 6b induced caspase-dependent apoptosis and cell cycle arrest at the G2/M phase. Finally, a molecular docking simulation was performed for compound 6b to predict the potential ligand–protein interactions with the active sites of the EGFR, HER2, and VEGFR2 proteins.

Schlagwörter

Stichwörter der Autor:innen

N-acylhydrazone (NAH)anticancerbenzoxazoledockingisatinsprotein kinases

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11541, Saudi Arabia.

ORCID-Profile: Mohammed M Alanazi

Förderung

  • Research & Innovation "Ministry of Education" in Saudi Arabia
  • Deputyship for Research & Innovation “Ministry of Education”

Zitieren

APA

Alanazi, M. M., Aldawas, S., & Alsaif, N. A. (2023). Design, Synthesis, and Biological Evaluation of 2-Mercaptobenzoxazole Derivatives as Potential Multi-Kinase Inhibitors. Pharmaceuticals, 16(1), 97. https://doi.org/10.3390/ph16010097

Vancouver

Alanazi MM, Aldawas S, Alsaif NA. Design, Synthesis, and Biological Evaluation of 2-Mercaptobenzoxazole Derivatives as Potential Multi-Kinase Inhibitors. Pharmaceuticals. 2023;16(1):97. doi:10.3390/ph16010097

BibTeX
@article{Alanazi2023,
  author = {Alanazi, Mohammed M and Aldawas, Saleh and Alsaif, Nawaf A},
  title = {Design, Synthesis, and Biological Evaluation of 2-Mercaptobenzoxazole Derivatives as Potential Multi-Kinase Inhibitors},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {1},
  pages = {97},
  doi = {10.3390/ph16010097}
}
Kostenlos starten →